Market Overview

UPDATE: Goldman Sachs Upgrades Zimmer Holdings to Neutral on Improving Orthopedic Volumes

Related ZMH
Brean Capital Cashes Out Of Zimmer Holdings, Downgrades Stock On 'Uncertainty'
Benzinga's Top Downgrades

Goldman Sachs raised its rating on Zimmer Holdings (NYSE: ZMH) from Sell to Neutral and increased its price target from $58 to $70.

Goldman Sachs noted, "Our investment thesis is based on the following factors: (1) improving outlook on US orthopaedic surgical volumes; (2) decelerating rates of pricing pressure; (3) capital allocation optionality with the potential for larger free cash flow returns to shareholders; and (4) shares appear fairly valued at current levels. Since being added to the Americas Sell List on August 9, 2011, ZMH shares are up 20.5% vs. the S&P 500 up 21.0%. On a trailing 12-month basis, ZMH is +33.0% vs. the S&P 500 +13.0%."

Zimmer Holdings closed at $65.50 on Monday.

Latest Ratings for ZMH

Jun 2015Brean CapitalDowngradesBuyHold
May 2015JefferiesMaintainsBuy
May 2015BarclaysMaintainsOverweight

View More Analyst Ratings for ZMH
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Intraday Update Analyst Ratings


Related Articles (ZMH)

View Comments and Join the Discussion!